Mentax (1% butenafine HCl cream)

The following drug information is obtained from various newswires, published medical journal articles, and medical conference presentations.

Company:

Approval Status:

Approved December 1997

Specific Treatments:

athlete's foot

Find Related Trials for The Following Conditions

General Information

A one-week dosing regimen for Mentax has been approved for the treatment of athlete's foot. The dosing regimen allows topical application either twice-a-day for seven days, or once-a-day for four weeks for more severe cases of the fungus. Mentax is the only topical antifungal product approved in the U.S. which has such a one-week dosing regimen.